EMEA-001964-PIP01-16-M04

Invented name	Epidyolex
Active substance	Cannabidiol
Therapeutic area	Neurology
Decision number	P/0218/2022
PIP number	EMEA-001964-PIP01-16-M04
Pharmaceutical form(s)	Oral solution
Condition(s) / indication(s)	Treatment of seizures associated with Dravet Syndrome (DS) Treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) Treatment of seizures associated with Tuberous Sclerosis Complex (TSC)
Route(s) of administration	Oral use
Contact for public enquiries	GW Pharma (International) B.V. E-mail: info@gwpharm.com Tel: +44 1223266800
Decision type	PM: decision on the application for modification of an agreed PIP

Add your rating

★ ★ ★ ★ ★